n-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide has been researched along with Colitis Gravis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caron, B; Gonzalez, F; Paupard, T; Peyrin-Biroulet, L; Siproudhis, L | 1 |
| Bourreille, A; Drissi, F; Meurette, G; Neunlist, M | 1 |
2 other study(ies) available for n-(8-aminohexyl)-5-iodonaphthalene-1-sulfonamide and Colitis Gravis
| Article | Year |
|---|---|
Real-world evidence of quality of life improvement in patients with distal ulcerative colitis treated by mesalazine: the Quartz study.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Colitis, Ulcerative; Humans; Inflammatory Bowel Diseases; Mesalamine; Proctocolitis; Quality of Life; Quartz; Ulcer | 2022 |
Sacral neuromodulation for refractory ulcerative colitis: safety and efficacy in a prospective observational series of eight patients.
Topics: Animals; Colitis, Ulcerative; Electric Stimulation Therapy; Humans; Pilot Projects; Prospective Studies | 2023 |